iPSCs
Resolution Therapeutics and CCRM Sign Collaboration Agreement to Develop and Scale Up Manufacturing for Induced Pluripotent Stem Cell (iPSC)-Derived Macrophage Cell Therapies
CCRM
PR-M11-22-04Nov 07, 2022
Biomanufacturing Facility
OmniaBio, CCRM and Stakeholders Celebrate Commencement of Construction of Hamilton Biomanufacturing Facility
OmniaBio
PR-M10-22-05Oct 06, 2022